Trends in intracranial glioma incidence and mortality in the United States, 1975-2018
10.3389/fonc.2021.748061 · 2021
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
10.1016/s1470-2045(09)70025-7 · 2009
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
10.1093/neuonc/now102 · 2016
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality
10.1016/j.ejca.2012.04.011 · 2012
Extent and kinetics of recovery of occult spinal cord injury
10.1016/s0360-3016(01)01599-1 · 2001
Spinal cord tolerance to reirradiation with single-fraction radiosurgery: a swine model
10.1016/j.ijrobp.2011.08.030 · 2012
Reirradiation tolerance of the human brain
10.1016/j.ijrobp.2007.08.015 · 2008
Update of human spinal cord reirradiation tolerance based on additional data from 38 patients
10.1016/j.ijrobp.2006.07.1383 · 2006
Radiation dose–volume effects in the spinal cord
10.1016/j.ijrobp.2009.04.095 · 2010
Technical advances in radiation therapy for brain Tumors
10.21873/anticanres.12954 · 2018
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the radiation oncology group (ROG) of the German Cancer consortium (DKTK)
10.1002/cam4.1425 · 2018
Validation of an established prognostic score after re-irradiation of recurrent glioma
10.1080/0284186x.2016.1276621 · 2017
Radiation therapy for glioblastoma: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology guideline
10.1200/jco.2016.70.7562 · 2017
Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system
10.1186/s13014-017-0930-9 · 2017
Independent validation of a new reirradiation risk score (RRRS) for glioma patients predicting post-recurrence survival: a multicenter DKTK/ROG analysis
10.1016/j.radonc.2018.01.011 · 2018
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival
2019
Stereotactic radiosurgery for recurrent high-grade gliomas: a systematic review
10.1007/s11060-025-05156-0 · 2025
The CyberKnife robotic radiosurgery system in 2010
10.1177/153303461000900502 · 2010
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis
10.1186/s13014-023-02236-1 · 2023
Re-irradiation for recurrent glioblastoma (GBM): a systematic review and meta-analysis
10.1007/s11060-018-03064-0 · 2018
Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice
10.1126/scitranslmed.3008973 · 2014
Irradiation in a flash: unique sparing of memory in mice after whole brain irradiation with dose rates above 100 Gy/s
10.1016/j.radonc.2017.05.003 · 2017
Proton FLASH radiotherapy for the treatment of symptomatic bone metastases: the FAST-01 nonrandomized trial
10.1001/jamaoncol.2022.5843 · 2023
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach
10.1186/s13014-024-02419-4 · 2024
A universal range shifter and range compensator can enable proton pencil beam scanning single-energy Bragg peak FLASH-RT treatment using current commercially available proton systems
10.1016/j.ijrobp.2022.01.009 · 2022
Radiation therapy for brain metastases: an ASTRO clinical practice guideline
10.1016/j.prro.2022.02.003 · 2022
ESTRO/EANO recommendation on reirradiation of glioblastoma
10.1016/j.radonc.2024.110696 · 2025
A story of hypofractionation and the table on the wall
10.1016/j.ijrobp.2021.09.027 · 2022
Radiation therapy oncology group radiosurgery quality assurance guidelines
10.1016/0360-3016(93)90548-a · 1993
An ultra-high dose rate Bragg peak tracking technique provides more affordable proton radiotherapy for cancer patients: from principle to experimental validation
10.1016/j.radonc.2025.110800 · 2025
A novel proton pencil beam scanning FLASH RT delivery method enables optimal OAR sparing and ultra-high dose rate delivery: a comprehensive dosimetry study for lung Tumors
10.3390/cancers13225790 · 2021
Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy
10.1002/mp.15894 · 2022
Proton Bragg peak FLASH enables organ sparing and ultra-high dose-rate delivery: proof of principle in recurrent head and neck cancer
10.3390/cancers15153828 · 2023
Pencil beam scanning proton Bragg peak conformal FLASH in prostate cancer stereotactic body radiotherapy
10.3390/cancers16040798 · 2024
Pencil beam scanning Bragg peak FLASH technique for ultra-high dose rate intensity-modulated proton therapy in early-stage breast cancer treatment
10.3390/cancers15184560 · 2023
FLASH stereotactic body radiation therapy for spine Tumors using a single-energy proton pristine Bragg peak delivery technique
2025
Use of apertures in single-energy pristine Bragg peak FLASH radiotherapy
10.1002/acm2.70593 · 2026
Development of the open-source dose calculation and optimization toolkit matRad
10.1002/mp.12251 · 2017
Quantitative assessment of 3D dose rate for proton pencil beam scanning FLASH radiotherapy and its application for lung hypofractionation treatment planning
10.3390/cancers13143549 · 2021
A framework for defining FLASH dose rate for pencil beam scanning
10.1002/mp.14456 · 2020
